Catalent Biologics recently announced its acquisition of Paragon for $1.2 billion. As CEO, one of Pete’s main focuses has been putting together a “rockstar” leadership team, which he describes as one of the biggest factors to Paragon’s success. Pete also clues us into some of the things young companies should know about preparing for the capital markets and one of the leadership qualities CEOs should have to successfully engage with potential investors.